Hefei Lifeon Pharmaceutical (003020.SZ): The application for the listing of cefditoren pivoxil raw materials has been approved.

date
15:45 20/12/2024
avatar
GMT Eight
Cubist Pharmaceuticals (003020.SZ) issued an announcement. Recently, the company received a notification from the National Medical Products Administration regarding the addition of...
Hefei Lifeon Pharmaceutical (003020.SZ) announced that the company has recently received the approval notice for the market application of gemifloxacin from the National Medical Products Administration. Gemifloxacin is a fourth-generation fluoroquinolone broad-spectrum antibacterial drug developed by the Japanese company Kyorin. It is mainly used for various infectious diseases caused by sensitive pathogens.